Advanced searches left 3/3

Tcd - ClinicalTrials.gov

Summarized by Plex Scholar
Last Updated: 17 November 2022

* If you want to update the article please login/register

Early Feasibility Evaluation of Transmural Systems Transcaval Closure Device (TCD) for Transcaval Access Ports During Transcatheter Aortic Valve Replacement (TAVR)

Patients who are not eligible for artery access are unable to reach the abdominal aorta from the neighboring inferior vena cava. Transcatheter aortic valve replacement in patients with non-ethical artery access is done. The Transcaval closure unit will be tested for safety and effectiveness in patients with transcaval access to TAVRs that are ineligible for femoral artery access for TAVR.

Source link: https://clinicaltrials.gov/ct2/show/NCT03432494

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions